Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Developing classification criteria for skin-predominant dermatomyositis: the Delphi process.
Concha JSS, Pena S, Gaffney RG, Patel B, Tarazi M, Kushner CJ, Merola JF, Fiorentino D, Dutz JP, Goodfield M, Nyberg F, Volc-Platzer B, Fujimoto M, Ang CC, Werth VP; Skin Myositis Delphi Group. Concha JSS, et al. Among authors: fujimoto m. Br J Dermatol. 2020 Feb;182(2):410-417. doi: 10.1111/bjd.18096. Epub 2019 Sep 29. Br J Dermatol. 2020. PMID: 31049930
Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
Ueda-Hayakawa I, Hamaguchi Y, Okiyama N, Motegi S, Yamaoka T, Miyake S, Higashi A, Okamoto H, Takehara K, Fujimoto M. Ueda-Hayakawa I, et al. Among authors: fujimoto m. Br J Dermatol. 2019 Apr;180(4):881-887. doi: 10.1111/bjd.17098. Epub 2018 Oct 10. Br J Dermatol. 2019. PMID: 30120913
Diffuse erythema with 'angel wings' sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis.
Inoue S, Okiyama N, Shobo M, Motegi S, Hirano H, Nakagawa Y, Saito A, Nakamura Y, Ishitsuka Y, Fujisawa Y, Watanabe R, Fujimoto M. Inoue S, et al. Among authors: fujimoto m. Br J Dermatol. 2018 Dec;179(6):1414-1415. doi: 10.1111/bjd.17026. Epub 2018 Sep 21. Br J Dermatol. 2018. PMID: 30022478 No abstract available.
Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi Y, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K. Matsushita T, et al. Among authors: fujimoto m. Br J Dermatol. 2017 Feb;176(2):395-402. doi: 10.1111/bjd.14882. Epub 2017 Jan 19. Br J Dermatol. 2017. PMID: 27452897
2,454 results